HSCT
-
News
SEVERE APLASTIC ANAEMIA | Stem Cell Transplant Opens New Possibilities
Severe aplastic anaemia is a rare but serious disorder in which the bone marrow fails to produce enough red and white blood cells or platelets. This results in fatigue, infections,…
Read More » -
News
HSCT | Briquilimab Granted Orphan Drug Designation By The European Commission
Previously, the U.S. Food and Drug Administration (FDA) granted orphan drug designation to briquilimab in HCT, as well as rare pediatric disease designation for the treatment of severe combined immunodeficiency…
Read More »